After gains of 2.4% this morning, Sanofi ADS shares are now trading at $46.43. Read below for the essential facts about this stock:
-
Sanofi ADS has logged a -21.5% 52 week change, compared to 20.2% for the S&P 500
-
SNY has an average analyst rating of buy and is -24.37% away from its mean target price of $61.39 per share
-
Its trailing earnings per share (EPS) is $3.0, which brings its trailing Price to Earnings (P/E) ratio to 15.5. The Health Care sector's average P/E ratio is 22.94
-
The company's forward earnings per share (EPS) is $4.94 and its forward P/E ratio is 9.4
-
The company has a Price to Book (P/B) ratio of 0.81 in contrast to the Health Care sector's average P/B ratio is 3.19
-
The current ratio is currently 1.5, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
SNY has reported YOY quarterly earnings growth of 266.6% and gross profit margins of 0.7%
-
The company's free cash flow for the last fiscal year was $9.08 Billion and the average free cash flow growth rate is 3.7%